Hoffmann-La Roche: Psoriasis trials
The registry lists 14 Psoriasis studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 1Phase 2 1Phase 3 5Phase 4 5No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the ScalpCompletedNCT00669214Phase 4Results posted
- A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF AgentCompletedNCT00336973Phase 4Results posted
- A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.CompletedNCT00504270Phase 2
- A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.CompletedNCT00437619Phase 4
- A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque PsoriasisCompletedNCT00382512Phase 1
- A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic TherapiesCompletedNCT00338143Phase 3
- A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or FeetCompletedNCT00312026Phase 4
- A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic TherapyCompletedNCT00109317Phase 3
- A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390gCompletedNCT00109252Phase 3
- An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)CompletedNCT00097240
- A Study to Evaluate Raptiva in Combination With Topical Psoriasis TherapiesCompletedNCT00096980Phase 4
- A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)CompletedNCT00096928
- A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600gCompletedNCT00096603Phase 3
- Treatment of Psoriasis Using Acitretin in HIV-Positive PatientsCompletedNCT00002143Phase 3